Medical Research News

RSS

Developing a COVID-19 antigen test

News-Medical speaks to Alastair Smith, the CEO of Avacta, about the process behind their newly developed antigen test for COVID-19.

From Avacta Life Sciences Ltd. 15 May 2020

Unique bone graft biomaterial eliminates pain

A new recipe for a bone-graft biomaterial that is supercooled before application should make it easier to meet dental patients' expectation of a good-looking smile while eliminating the pain associated with harvesting bone from elsewhere in their body.

15 May 2020

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Over 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.

15 May 2020

Study shows the combined effect of inherited and acquired mutations on cancer development

The common belief that tumors arise via activation of a few genes that "drive" cancer development is unsupported by a widespread investigation into those genes and others in three large patient genetic databases, according to a study led by Yale Cancer Center researchers.

15 May 2020

Biologic drug can help treat contact dermatitis

APOSEC it is a biologic wound-healing agent developed by thoracic surgeon Hendrik Jan Ankersmit from MedUni Vienna.

15 May 2020

Adaptations to COVID-19 can be used improve other health challenges

The world is currently facing a global pandemic without precedence.

15 May 2020

First cellular immunology data to help guide social distancing recommendations

Scientists around the world are racing to develop a vaccine to protect against COVID-19 infection, and epidemiologists are trying to predict how the coronavirus pandemic will unfold until such a vaccine is available.

15 May 2020

Digital technology applications will play a key role in addressing COVID-19 crisis

Artificial intelligence, machine learning, blockchain, and other key digital technology applications will play a vital role addressing the new healthcare challenges triggered by the COVID-19 pandemic, according to a peer-reviewed Special Issue of OMICS: A Journal of Integrative Biology.

15 May 2020

More research is needed to determine if fecal matter spreads COVID-19, say researchers

Early studies show evidence of COVID-19 genetic material in fecal matter, but more work is needed to determine if the virus can be spread through stool, according to a new review paper from a Rice University epidemiologist.

15 May 2020

Metabolic signature determines adherence and metabolic response to Mediterranean diet

A newly identified "metabolic signature" can evaluate an individual's adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research led by Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain.

15 May 2020

Researchers investigate the troubling trend of heart injury in COVID-19 patients

Researchers are finding about half of all patients with COVID-19 admitted to an intensive care unit have heart damage.

15 May 2020

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Diagnostics company SphingoTec GmbH ("sphingotec") and 4TEEN4 Pharmaceuticals GmbH ("4TEEN4") announced today the publication of new data showing that high blood levels of Dipeptidyl Peptidase 3 (DPP3) are indicating upcoming multiple organ failure and mortality risk in burn patients.

15 May 2020

Hot temperatures, air pressure, UV radiation may decrease COVID-19 incidence

A new scientific paper published on the preprint server medRxiv shows that the spread of COVID-19, the respiratory illness that has spread across the world to kill hundreds of thousands in 2020, shows that weather conditions reduce the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 May 2020

Research investigates COVID-19 virus origin using artificial intelligence (AI)

The coronavirus responsible for the COVID-19 pandemic has spread across the globe with unprecedented speed and lethality, killing hundreds of thousands of people and forcing countries’ entire populations to self-quarantine.

15 May 2020

Mental health of 41% of people in the UK is at risk, study reveals

An international study, led by the Universitat Oberta de Catalunya (Spain) spin-off Open Evidence, has revealed that the mental health of 41% of the UK population is at risk as a result of the coronavirus crisis.

15 May 2020

Bactiguard donates money to facilitate COVID-19 research

To contribute to the research on COVID-19, Bactiguard donates SEK 120,000 to Karolinska Institutet (KI) at Danderyd Hospital.

15 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

In an article published today in Cell Host and Microbe, Professor Kanta Subbarao stressed the importance of detecting a neutralizing antibody response in recovered COVID-19 patients, and of studies of COVID-19 vaccines in animal models.

15 May 2020

Viral shedding among pre-symptomatic COVID-19 patients finds study

Researchers from Bangalore, India, have found that 68 percent of pre-symptomatic patients with COVID-19 may be shedding the virus and potentially infecting others. Their study titled, “Quantitative COVID-19 infectiousness estimate correlating with viral shedding and culturability suggests 68% pre-symptomatic transmissions,” was published on the open-access preprint server Medrxiv.

15 May 2020

Viral shedding seen in plasma donors who have recovered from COVID-19

Researchers from the University of Wisconsin-Madison have found that plasma donors who have recovered from the deadly COVID-19 infection were still shedding viral RNA. This could be significant they write in their article titled, “Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors,” that is published on the preprint server Medrxiv* prior to peer review.

15 May 2020

Medical Research News

Developing a COVID-19 antigen test

Unique bone graft biomaterial eliminates pain

Study: Over 28 million elective operations could be cancelled due to COVID-19 pandemic

Study shows the combined effect of inherited and acquired mutations on cancer development

Biologic drug can help treat contact dermatitis

Adaptations to COVID-19 can be used improve other health challenges

First cellular immunology data to help guide social distancing recommendations

Digital technology applications will play a key role in addressing COVID-19 crisis

More research is needed to determine if fecal matter spreads COVID-19, say researchers

Metabolic signature determines adherence and metabolic response to Mediterranean diet

Researchers investigate the troubling trend of heart injury in COVID-19 patients

High DPP3 concentration in the blood predicts multiple organ failure in burn patients

Hot temperatures, air pressure, UV radiation may decrease COVID-19 incidence

Research investigates COVID-19 virus origin using artificial intelligence (AI)

Mental health of 41% of people in the UK is at risk, study reveals

Bactiguard donates money to facilitate COVID-19 research

Precision medicine can determine the best drug treatment for severe heart disease

Importance of detecting neutralizing antibody response in recovered COVID-19 patients

Viral shedding among pre-symptomatic COVID-19 patients finds study

Viral shedding seen in plasma donors who have recovered from COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News